Company Filing History:
Years Active: 2024
Title: Ozgur Akcan - Innovative Mind in Pharmaceutical Dosage Forms
Introduction
Ozgur Akcan is a notable inventor based in Parlin, New Jersey, who has made significant contributions to the field of pharmaceutical science. With two patents to his name, he focuses on creating advanced dosage forms that enhance the delivery of active agents in medications. His work is pivotal in providing solutions for effective drug delivery systems.
Latest Patents
Ozgur's latest patents include innovative pharmaceutical dosage forms that feature unique core-shell structures. The first patent describes a solid dosage form that consists of a core comprising a first matrix formulation, which includes at least one active agent from a selection of agents A and B. Encased within this core is a shell that features a second matrix formulation, designed to optimize the ratio of the first to the second formulation between 1:10 and 4:1. This design aims to offer extended release capabilities for at least one active agent.
The second patent concerns an extended release oral solid dosage form comprising an extended release matrix formulation. This formulation is characterized by the inclusion of at least one active agent, one anionic surfactant, and a minimum of 40% by weight of polyethylene oxide. Additionally, it details a specific molar ratio of the anionic surfactant to the active agent, ranging from about 1:2 to about 10:1, ensuring effective drug release profiles.
Career Highlights
Ozgur Akcan currently works at Purdue Pharma L.P., where he collaborates with leading experts in pharmaceuticals. His work at Purdue Pharma has focused on enhancing drug formulations and improving patient outcomes through innovative pharmaceutical technologies. His patents are testament to his commitment to developing advanced therapeutic solutions.
Collaborations
Throughout his career, Ozgur has had the opportunity to collaborate with esteemed colleagues such as Richard O. Mannion and Stephen C. Harris. These collaborations have allowed him to leverage diverse expertise in the formulation and delivery of pharmaceutical products, furthering the impact of his work in the industry.
Conclusion
Ozgur Akcan’s contributions to the field of pharmaceutical dosage forms exemplify the power of innovation in improving healthcare solutions. His patents not only represent a step forward in drug delivery but also highlight the importance of collaborative efforts in scientific advancements. With his continued work at Purdue Pharma and partnerships with other professionals, Ozgur is poised to make even greater strides in the realm of pharmaceuticals.